Investor directoryNewton Biocapital
Newton Biocapital leverages strong ties to life sciences ecosystems in Europe and Japan to unlock unique investment opportunities.
What they invest in
Sectors
Geographies
EuropeJapan
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- Brussels, Belgium
- Founded
- 2017
Portfolio companies
More portfolio companies
Accutar BiotechAbolerIS PharmaCellaïonChromacurePRISM BioLab (TKS: 206A)EditForceActicor BiotechJ-Pharma (TKS: 520A)Synergia MedicalEpics TherapeuticsNeuVasQ BiotechnologiesSantero TherapeuticsTensegrity PharmaDeuterOncologySANTERODim3
Recent rounds
Augustine Therapeutics NV
€77.7MSeries AHealthTechNovo HoldingsleadJeitoleadNewton BiocapitalAsabys PartnersAdBio partnersPMV · +4 more in the source
Belgiumsiliconcanals.com
Rounds Newton Biocapital took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- How much does Newton Biocapital typically invest?
- Newton Biocapital states a typical cheque of €1M – €30M.
- Which stages does Newton Biocapital invest in?
- Newton Biocapital invests at Seed, Series A and Series B.
- Where is Newton Biocapital based?
- Newton Biocapital is headquartered in Brussels, Belgium.
Does Newton Biocapital fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you Newton Biocapital? Tell us what to correct and we will update it — or ask us to remove the entry.